RiaSTAP
Fibrinogen Human · Injection, Powder, Lyophilized, For Solution · Intravenous, Subcutaneous
No FDA structured label text is available for RiaSTAP. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Fibrinogen Human in 2 products
RiaSTAP NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 63833-891 | Fibrinogen Human 1300 mg/50mL Injection, Powder, Lyophilized, For Solution | CSL Behring GmbH | BLA |
| 63833-892 | Fibrinogen Human 2600 mg/100mL Injection, Solution | CSL Behring GmbH | BLA |
Frequently asked questions
Who makes RiaSTAP?
RiaSTAP is listed by 1 labeler in the FDA NDC directory, including CSL Behring GmbH.